---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-094588"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2025-07-08T23:59:59+00:00"
generated_at: "2026-05-18T09:00:12.692452+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# RxSight preliminary Q2 revenue $33.6M, down 4% YoY; cuts FY2025 guidance to $120-130M

## Summary
- Preliminary Q2 revenue ~$33.6M, down 4% YoY and 11% sequentially; LAL volume +13% YoY, LDD sales -49% YoY.
- FY2025 revenue guidance slashed to $120-130M (from $160-175M), implying 7-14% decrease from 2024.
- Gross margin guidance raised to 72-74% (from 71-73%); operating expense guidance $145-155M, up 7-14% YoY.
- Installed LDD base of 1,084 units (+34% YoY); management cites underperformance and plans to refocus commercial strategy.
- Cash $227.5M as of June 30, 2025, down $1.8M from March 31, 2025.

## SEC filing metadata
- accession: 0000950170-25-094588
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2025-07-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017025094588/0000950170-25-094588-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017025094588/rxst-20250708.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-094588
- JSON: https://secwatch.observer/filing/0000950170-25-094588.json
- Plain text: https://secwatch.observer/filing/0000950170-25-094588.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.